Table 2.

Sex differences in overall post LT outcomes.

Outcome	Sex difference	Comment
Patient/graft survival	Controversial	German study identified higher 90-day mortality in women [20]. U.S. study did not identify sex difference [21]
Rejection risk	No	No overall sex difference in acute or chronic rejection [29-31] though higher risk of early acute rejection in women with HCV [28]. Women less likely to wean from IMS and develop immune tolerance [25]
Quality of life	Yes	Considerable variability in the definition of specific QOL indicators though differences in sexual function, emotional and physical well-being are apparent
Renal function	Yes	Women at higher risk of CKD post LT [16,32-34]
Post LT recovery and sarcopenia	Yes	In men, but less so women, sarcopenia is associated with worse post LT survival and post operative recovery [36-37]